ZURA: Zura Bio Limited Stock

by  •  • Comments Off on ZURA: Zura Bio Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 111.98
Enterprise Value ($M) -58.46
Book Value ($M) 170.83
Book Value / Share 2.62
Price / Book 0.66
NCAV ($M) 170.73
NCAV / Share 2.61
Price / NCAV 0.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.59

Liquidity (mrq)
Quick Ratio 10.36
Current Ratio 10.36

Balance Sheet (mrq) ($M)
Current Assets 188.97
Assets 189.07
Liabilities 18.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 9.99 7.09
11-14 13G/A Suvretta Capital Management, Llc 7.60 70.56
11-14 13G ADAR1 Capital Management, LLC 5.10
11-14 13G/A Great Point Partners Llc 5.12 -0.95
09-23 13G/A Athanor Capital, Lp 1.49
05-02 13G Ra Capital Management, L.p. 5.10
04-22 13G/A Deep Track Capital, LP 9.34 47.83
02-14 13G/A Access Industries Management, Llc 9.90 4.49
02-12 13G/A Alberta Investment Management Corp 0.00
02-06 13G/A Hudson Bay Capital Management LP 0.85

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-05-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 48,163 181,171 26.58
2025-02-03 65,174 206,687 31.53
2025-01-31 82,269 361,881 22.73
2025-01-30 152,885 3,373,850 4.53

(click for more detail)

Similar Companies
XBIO – Xenetic Biosciences, Inc. XCUR – Exicure, Inc.
XFOR – X4 Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io